Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Hodgkin Lymphoma Treatment Revolution: Advanced Drug Screening in a 3D-Biomimetic Tumour-Associated Macrophage-Integrated Model
EF 2023-24
Résumé
Our research zeroes in on Hodgkin Lymphoma (HL), a cancer type involving immune cells known as tumour-associated macrophages (TAMs), which assist in its growth. By using a sophisticated three-dimensional biomaterial closely resembling human tissue, we've previously discovered drugs that have the potential to disrupt the support TAMs provide to HL. Now, we're broadening our approach. We're planning to assess a variety of drugs within this biomaterial to pinpoint new ones that can interfere with the communication between TAMs and cancer cells, ultimately weakening their support system.
Our strategy involves three main steps. Initially, we'll conduct screenings of multiple drugs to identify those that could potentially disrupt the cooperation between TAMs and cancer cells. Then, we'll delve deeper into understanding how these drugs work, examining their impact on cell communication. Lastly, we'll validate the effectiveness of these drugs within our 3-D model, using tumour cells directly obtained from HL patients.
The success of this endeavour has the potential to bring about a revolution in HL treatments. Additionally, the insights gained could have broader implications, potentially transforming how we approach cancer care on a global scale and benefiting other types of cancer beyond HL.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
507055
Name
Chin Allysia A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hodgkin Lymphoma Treatment Revolution: Advanced Drug Screening in a 3D-Biomimetic Tumour-Associated Macrophage-Integrated Model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Hydrogel Model; Anti-Cancer Drugs; Gelatin-Oxyamine Chemistry; High-Throughput Drug Screen; Hodgkin Lymphoma; Immunomodulators; Macrophage-Tumor Cell Interactions; Multi-Omics Analyses; Personalized-Anti Cancer Therapeutics; Tumour Microenvironment
Abstract
Our research zeroes in on Hodgkin Lymphoma (HL), a cancer type involving immune cells known as tumour-associated macrophages (TAMs), which assist in its growth. By using a sophisticated three-dimensional biomaterial closely resembling human tissue, we've previously discovered drugs that have the potential to disrupt the support TAMs provide to HL. Now, we're broadening our approach. We're planning to assess a variety of drugs within this biomaterial to pinpoint new ones that can interfere with the communication between TAMs and cancer cells, ultimately weakening their support system.
Our strategy involves three main steps. Initially, we'll conduct screenings of multiple drugs to identify those that could potentially disrupt the cooperation between TAMs and cancer cells. Then, we'll delve deeper into understanding how these drugs work, examining their impact on cell communication. Lastly, we'll validate the effectiveness of these drugs within our 3-D model, using tumour cells directly obtained from HL patients.
The success of this endeavour has the potential to bring about a revolution in HL treatments. Additionally, the insights gained could have broader implications, potentially transforming how we approach cancer care on a global scale and benefiting other types of cancer beyond HL.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chin, Allysia A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~